Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-04 07:13 am Purchase | 2022-12-31 | 13G | Onconetix, Inc. ONCO | SABBY MANAGEMENT, LLC | 356 11.000% | 356 (New Position) | Filing History |
| 2022-01-05 1:05 pm Purchase | 2021-12-31 | 13G | Skye Bioscience, Inc. SKYE | SABBY MANAGEMENT, LLC | 8,000 11.000% | 8,000 (New Position) | Filing History |
| 2022-01-05 12:35 pm Sale | 2021-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | SABBY MANAGEMENT, LLC | 0 0.000% | -904,710 (Position Closed) | Filing History |
| 2022-01-05 12:29 pm Purchase | 2021-12-31 | 13G | Pulmatrix, Inc. PULM | SABBY MANAGEMENT, LLC | 180,852 11.000% | 82,087 (+83.11%) | Filing History |
| 2022-01-04 9:59 pm Sale | 2021-12-31 | 13G | SuperCom Ltd. SPCB | SABBY MANAGEMENT, LLC | 5,609 11.000% | -1,791 (-24.20%) | Filing History |
| 2022-01-04 9:43 pm Purchase | 2021-12-31 | 13G | Globus Maritime Limited GLBS | SABBY MANAGEMENT, LLC | 1,026,649 11.000% | 710,117 (+224.34%) | Filing History |
| 2022-01-04 9:23 pm Sale | 2021-12-31 | 13G | Gene Biotherapeutics, Inc. CRXM | SABBY MANAGEMENT, LLC | 0 0.000% | -1,435,917 (Position Closed) | Filing History |
| 2022-01-04 9:21 pm Sale | 2021-12-31 | 13G | GeoVax Labs, Inc. GOVX | SABBY MANAGEMENT, LLC | 0 0.000% | -25,152 (Position Closed) | Filing History |
| 2022-01-04 9:18 pm Purchase | 2021-12-31 | 13G | Cingulate Inc. CING | SABBY MANAGEMENT, LLC | 3,693 11.000% | 1,181 (+47.05%) | Filing History |
| 2022-01-04 9:16 pm Sale | 2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR | SABBY MANAGEMENT, LLC | 3,095,410 11.000% | -2,618,876 (-45.83%) | Filing History |
| 2022-01-04 9:13 pm Purchase | 2021-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 1,230,830 11.000% | 230,830 (+23.08%) | Filing History |
| 2022-01-04 9:11 pm Purchase | 2021-12-31 | 13G | Tantech Holdings Ltd TANH | SABBY MANAGEMENT, LLC | 645 11.000% | 4 (+0.55%) | Filing History |
| 2022-01-04 9:08 pm Sale | 2021-12-31 | 13G | Qualigen Therapeutics, Inc. QLGN | SABBY MANAGEMENT, LLC | 0 0.000% | -3,920 (Position Closed) | Filing History |
| 2022-01-04 9:06 pm Purchase | 2021-12-31 | 13G | HeartBeam, Inc. BEAT | SABBY MANAGEMENT, LLC | 483,320 11.000% | 83,320 (+20.83%) | Filing History |
| 2022-01-04 4:00 pm Sale | 2021-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | SABBY MANAGEMENT, LLC | 122 11.000% | -36 (-22.92%) | Filing History |
| 2022-01-04 3:40 pm Sale | 2021-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | SABBY MANAGEMENT, LLC | 174,300 11.000% | -50,700 (-22.53%) | Filing History |
| 2022-01-04 3:25 pm Purchase | 2021-12-31 | 13G | Recon Technology, Ltd. RCON | SABBY MANAGEMENT, LLC | 149,650 11.000% | 72,251 (+93.35%) | Filing History |
| 2022-01-04 11:31 am Sale | 2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | SABBY MANAGEMENT, LLC | 3,507 11.000% | -493 (-12.32%) | Filing History |
| 2022-01-04 11:08 am Purchase | 2021-12-31 | 13G | Aditxt, Inc. ADTX | SABBY MANAGEMENT, LLC | 0 11.000% | 0 (+12.18%) | Filing History |
| 2022-01-04 10:43 am Sale | 2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | SABBY MANAGEMENT, LLC | 260,928 11.000% | -985,317 (-79.06%) | Filing History |